Neurocrine Biosciences, Inc. (NBIX) financial statements (2020 and earlier)

Company profile

Business Address 12780 EL CAMINO REAL
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments671651516307379194146
Cash and cash equivalents11214225583743145
Short-term investments558509261224305163101
Receivables1275631   0
Inventory, net of allowances, customer advances and progress billings1711    
Inventory1711     
Other current assets172083543
Total current assets:831738555310384198148
Noncurrent Assets
Operating lease, right-of-use asset74
Property, plant and equipment4234116332
Long-term investments and receivables300216247438237 
Long-term investments300216247438237 
Restricted cash and investments3555554
Other undisclosed noncurrent assets56      
Total noncurrent assets:4752552635591456
TOTAL ASSETS:1,306993818365475243155
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:141865426221811
Accounts payable 1465300
Accrued liabilities 38182119128
Employee-related liabilities392725  73
Other undisclosed accounts payable and accrued liabilities10275    
Debt409      
Deferred revenue and credits 000 
Other liabilities1520    
Other undisclosed current liabilities  144(3)0
Total current liabilities:565885430261612
Noncurrent Liabilities
Long-term debt and lease obligation496388370    
Long-term debt, excluding current maturities409388370    
Operating lease, liability87
Liabilities, other than long-term debt171813121222
Deferred revenue and credits13121222
Deferred rent credit 18
Other liabilities17  0000
Other undisclosed noncurrent liabilities(409)1888121720
Total noncurrent liabilities:10442439120251923
Total liabilities:66951244550503434
Stockholders' equity
Stockholders' equity attributable to parent637481372315424209120
Common stock0000000
Additional paid in capital1,7681,6601,5731,3711,3411,035886
Accumulated other comprehensive income (loss)1(2)(2)(0)(1)(0)0
Accumulated deficit(1,133)(1,178)(1,199)(1,056)(915)(826)(766)
Total stockholders' equity:637481372315424209120
TOTAL LIABILITIES AND EQUITY:1,306993818365475243155

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues788451162152033
Revenue, net1621520 3
Financial services revenue 333 
Cost of revenue
(Cost of Goods and Services Sold)
 (5)(1)    
Gross profit:788446160152033
Operating expenses(716)(414)(293)(162)(114)(64)(53)
Other undisclosed operating income (loss) 51  (3) 
Operating income (loss):7237(131)(147)(94)(64)(50)
Nonoperating income (expense)(26)(15)(11)6544
Investment income, nonoperating 163240
Interest and debt expense(32)(31)(20)    
Income (loss) from continuing operations before equity method investments, income taxes:15(9)(162)(141)(89)(61)(46)
Other undisclosed income from continuing operations before income taxes3231     
Income (loss) from continuing operations before income taxes:4722(162)(141)(89)(61)(46)
Income tax expense(10)(1)     
Net income (loss):3721(162)(141)(89)(61)(46)
Other undisclosed net income attributable to parent  20    
Net income (loss) available to common stockholders, diluted:3721(143)(141)(89)(61)(46)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):3721(162)(141)(89)(61)(46)
Comprehensive income (loss):3721(162)(141)(89)(61)(46)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3(0)181(1)(0)0
Comprehensive income (loss), net of tax, attributable to parent:4021(144)(140)(90)(61)(46)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: